Clinical Trials Browser

Phase 2 × dapagliflozin × 90 days × Clear all

NCT07018622 2026-03-11

DAPA-ARMOR

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07310433 2025-12-30

Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms